drugset / Trial / NCT03529942
Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.
Timeline
- Start
- 2018-04-24
- Primary completion
- 2019-11-08
- Completion
- 2020-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tafamidis | Unknown | 32 mg | Other |